Year archive

ADDvise Group B — 2022 filings

All 71 regulatory filings released by ADDvise Group B (ADDV) in 2022, sourced directly from the official regulator.

71 Filings

2022 Period

2022 filings (71)

Filing	Released	Lang
ADDvise erhåller order till ett värde av 1,2 MUSD Regulatory Filings	2022-12-20	Swedish
ADDvise receives order worth USD 1.2 million Regulatory Filings	2022-12-20	English
Fredrik Mella utses till vice VD för ADDvise Group Board/Management Information	2022-12-19	Swedish
Fredrik Mella is appointed Senior Vice President of ADDvise Group Board/Management Information	2022-12-19	English
ADDvise erhåller order till ett värde av 1,5 MUSD Regulatory Filings	2022-12-19	Swedish
ADDvise receives order worth USD 1.5 million Regulatory Filings	2022-12-19	English
ADDvise receives order worth USD 2.1 million Regulatory Filings	2022-12-16	English
ADDvise erhåller order till ett värde av 2,1 MUSD Regulatory Filings	2022-12-16	Swedish
Obligationsinnehavare godkänner ändring av obligationsvillkor Capital/Financing Update	2022-12-15	Swedish
Bondholders approve amendment to bond terms and conditions Capital/Financing Update	2022-12-15	English
ADDvise förvärvar CliniChain Holding B.V. M&A Activity	2022-12-06	Swedish
ADDvise acquires CliniChain Holding B.V. M&A Activity	2022-12-06	English
ADDvise receives order worth USD 1.7 million Regulatory Filings	2022-11-24	English
ADDvise erhåller order till ett värde av 1,7 MUSD Regulatory Filings	2022-11-24	Swedish
ADDvise Group har framgångsrikt placerat ytterligare seniort säkerställda obligationer om SEK 150 miljoner till par Capital/Financing Update	2022-11-23	Swedish
ADDvise Group successfully places subsequent senior secured bonds of SEK 150 million at par Capital/Financing Update	2022-11-23	English
ADDvise Group överväger emission av ytterligare seniort säkerställda obligationer Capital/Financing Update	2022-11-21	Swedish
ADDvise Group påkallar ändring av villkoren för bolagets seniort säkerställda obligationslån genom ett skriftligt förfarande Capital/Financing Update	2022-11-21	Swedish
ADDvise Group contemplates issuance of subsequent senior secured bonds Capital/Financing Update	2022-11-21	English
ADDvise Group calls for a change of the terms of the company’s senior secured bonds by initiation of a written procedure Capital/Financing Update	2022-11-21	English
Interim / Quarterly Report 2022 Interim / Quarterly Report 9M 2022	2022-10-28	Swedish
Interim / Quarterly Report 2022 Interim / Quarterly Report 9M 2022	2022-10-28	English
ADDvise Groups valberedning inför årsstämman 2023 Regulatory Filings	2022-10-14	Swedish
ADDvise Group’s nomination committee for the Annual General Meeting 2023 Regulatory Filings	2022-10-14	English
ADDvise tecknar avsiktsförklaring att förvärva CliniChain Holding B.V. M&A Activity	2022-09-06	Swedish
ADDvise signs Letter of Intent to acquire CliniChain Holding B.V. M&A Activity	2022-09-06	English
ADDvise erhåller order till ett värde av 640 000 USD Regulatory Filings	2022-08-31	Swedish
ADDvise receives order worth USD 640,000 Regulatory Filings	2022-08-31	English
Interim / Quarterly Report 2022 Interim / Quarterly Report H1 2022	2022-07-22	Swedish
Interim / Quarterly Report 2022 Interim / Quarterly Report H1 2022	2022-07-22	English
ADDvise erhåller ett tilldelningsbeslut till ett värde av cirka 2,4 MEUR Regulatory Filings	2022-07-19	Swedish
ADDvise receives allocation decision worth approximately EUR 2.4 million Regulatory Filings	2022-07-19	English
ADDvise receives order from Cadwell Industries worth approximately USD 1.7 million Regulatory Filings	2022-06-10	English
ADDvise erhåller order från Cadwell Industries till ett värde av cirka 1,7 MUSD Regulatory Filings	2022-06-10	Swedish
ADDvise förvärvar Seebreath AB M&A Activity	2022-05-16	Swedish
ADDvise acquires Seebreath AB M&A Activity	2022-05-16	English
Report from the annual general meeting of ADDvise Group AB (publ) 6th of May 2022 Declaration of Voting Results & Voting Rights Announcements	2022-05-06	English
Kommuniké från årsstämma i ADDvise Group AB (publ) den 6 maj 2022 AGM Information	2022-05-06	Swedish
Interim / Quarterly Report 2022 Interim / Quarterly Report	2022-04-22	Swedish
Interim / Quarterly Report 2022 Interim / Quarterly Report	2022-04-22	English
ADDvise acquires Surplus Diabetics, Inc. M&A Activity	2022-04-19	English
ADDvise förvärvar Surplus Diabetics, Inc. M&A Activity	2022-04-19	Swedish
Annual Report (ESEF) 2021 Annual Report (ESEF) FY 2021	2022-04-14	Swedish
ADDvise Group raises its EBITDA target for 2022 Regulatory Filings	2022-04-07	English
ADDvise Group höjer EBITDA-målet för 2022 Regulatory Filings	2022-04-07	Swedish
Kallelse till årsstämma i ADDvise Group AB (publ) AGM Information	2022-04-05	Swedish
Notice convening the Annual General Meeting of ADDvise Group AB (publ) Proxy Solicitation & Information Statement	2022-04-05	English
ADDvise erhåller order från SHCS på system för monitorering av vitala tecken inom äldrevården till ett värde av 2 MUSD Regulatory Filings	2022-03-18	Swedish
ADDvise receives order from SHCS on vital signs monitoring solution worth approximately USD 2 million Regulatory Filings	2022-03-18	English
ADDvise Group completes a directed new share issue of approximately SEK 100 million which was oversubscribed Share Issue/Capital Change	2022-03-14	English
ADDvise Group genomför en riktad nyemission om cirka 100 miljoner kronor som var övertecknad Share Issue/Capital Change	2022-03-14	Swedish
ADDvise Group announces intention to carry out a directed new share issue of approximately SEK 100 million Capital/Financing Update	2022-03-14	English
ADDvise Group offentliggör avsikt att genomföra en riktad nyemission om cirka 100 miljoner SEK Share Issue/Capital Change	2022-03-14	Swedish
ADDvise receives allocation decision worth approximately SEK 44 million Regulatory Filings	2022-03-09	English
ADDvise erhåller ett tilldelningsbeslut till värde av cirka 44 MSEK Regulatory Filings	2022-03-09	Swedish
ADDvise förvärvar JTECH Medical M&A Activity	2022-03-03	Swedish
ADDvise acquires JTECH Medical M&A Activity	2022-03-03	English
ADDvise signs Letter of Intent to acquire Seebreath AB M&A Activity	2022-02-28	English
ADDvise tecknar avsiktsförklaring att förvärva Seebreath AB M&A Activity	2022-02-28	Swedish
Annual Report 2022 Annual Report	2022-02-24	Swedish
Interim / Quarterly Report 2021 Interim / Quarterly Report Q4 2021	2022-02-24	English
ADDvise förvärvar Poly Pharmaceuticals, Inc. M&A Activity	2022-02-12	Swedish
ADDvise acquires Poly Pharmaceuticals, Inc. M&A Activity	2022-02-12	English
The nomination committee’s proposal of board of directors in ADDvise Group AB (publ) Board/Management Information	2022-02-04	English
Valberedningens förslag till styrelse i ADDvise Group AB (publ) Board/Management Information	2022-02-04	Swedish
ADDvise tecknar avsiktsförklaring att förvärva Surplus Diabetic, Inc. M&A Activity	2022-01-17	Swedish
ADDvise signs Letter of Intent to acquire Surplus Diabetic, Inc. M&A Activity	2022-01-17	English
Bondholders approve amendment to bond terms and conditions Capital/Financing Update	2022-01-14	English
Obligationsinnehavare godkänner ändring av obligationsvillkor Capital/Financing Update	2022-01-14	Swedish
ADDvise erhåller order till ett värde av 1,1 MUSD Regulatory Filings	2022-01-06	Swedish
ADDvise receives order worth USD 1.1 million Regulatory Filings	2022-01-06	English